Revenue
2017
2018
2019
2020
2021
2022
2023
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $4.4M | $0 | $121,939 | $1.8M | $4.3M | $4.9M | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | $0 | $52,213 | $426,547 | $821,623 | $907,752 | $987,901 | $1.0M | $1.3M | $1.9M | $1.6M | $1.6M | $447,136 | $0 |
| Research & development | $1.8M | $6.1M | $7.7M | $5.4M | $4.0M | $2.0M | $1.3M | $570,514 | $79,405 | $325,803 | $362,661 | $670,742 | $1.2M | $176,944 | $133,941 | $90,900 | $214,105 |
| Operating expenses | $18.0M | $15.2M | $14.0M | $16.9M | $10.4M | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | −$18.0M | −$15.2M | −$14.0M | −$12.6M | −$10.4M | −$6.8M | −$5.0M | −$2.3M | −$3.2M | −$2.7M | −$2.3M | −$2.6M | −$3.9M | −$2.2M | −$2.3M | −$1.0M | −$897,048 |
| EBITDAderived | −$18.0M | −$15.1M | −$13.7M | −$12.3M | −$10.2M | −$6.6M | −$4.8M | −$2.1M | −$3.2M | −$2.5M | −$2.0M | −$2.1M | −$3.5M | −$1.9M | −$1.9M | −$931,645 | −$897,048 |
| Net income | −$22.1M | −$16.6M | −$15.3M | −$20.1M | −$25.4M | −$13.6M | −$7.6M | −$3.3M | −$3.9M | −$1.7M | −$2.6M | −$1.0M | −$6.6M | −$2.7M | −$2.4M | −$1.1M | −$950,609 |
| Basic EPSper diluted share | — | — | — | — | -$0.86 | -$0.62 | -$0.42 | -$0.38 | -$1.01 | -$1.22 | -$2.33 | -$0.92 | -$0.05 | -$0.04 | -$0.06 | -$0.04 | -$0.03 |
| Diluted EPSper diluted share | -$0.39 | -$7.85 | — | — | -$0.86 | -$0.62 | -$0.42 | -$0.38 | -$1.01 | -$1.22 | -$2.33 | -$0.92 | -$0.05 | -$0.04 | -$0.06 | -$0.04 | -$0.03 |